Examining a Complex Heart Failure Case

Moderated by Prof Andrew JS Coats, Heart Research Institute, Sydney, AU, this broadcast explores how a complex heart failure patient would be treated by a multidisciplinary team.

Join Prof Andrew JS Coats, Dr Katherine Tuttle, Prof Silvio Inzucchi and Prof Richard Hobbs in this unique discussion, as they examine how the broader heart failure team can work together effectively and consider best practices for referral and initiation of foundational medical therapy.

Target Audience

This programme is intended to educate:

  • Cardiologists
  • Heart Failure Specialists
  • Primary Care Physicians
  • Nurses
  • Pharmacists
  • HCPs

Learning Objectives

Following attendance, physicians will be able to:

  • Identify individuals likely to have HFpEF from initial presentation
  • Refer suspected individuals for specialist assessment
  • Initiate GDMT for HF as soon as patients are stable 
  • Initiate GDMT in HF regardless of EF and phenotype
  • Initiate shared decision-making on complex HF patients with other members of the multidisciplinary team including cardiologists, GPs, nephrologists and diabetologists



This programme is supported by an unrestricted educational grant from AstraZeneca.



In compliance with EBAC guidelines, all speakers/chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations. The Organising Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CME activities. This programme is supported by an unrestricted educational grant from AstraZeneca.



Radcliffe Education requires contributors to our CME programmes to disclose any relevant financial relationships that have occurred within the past 12 months that could create a conflict of interest. These will be identified in the faculty section if applicable.

The session, ‘Examining a Complex Heart Failure Case’ is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 hour of external CME credits. 

Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).

Through an agreement between the European Board for Accreditation of Continuing Education for Health Professionals and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website.



There is no fee for taking part in this online learning activity.

Activities are designed to be completed within 60 minutes and must be completed by the registered user. Physicians should only claim credits for time spent on the activity. To successfully earn credit, participants must complete the activity in full in the indicated time frame.

To complete the course and claim certification participants must:

  • Read the course outline information supplied and complete pre-test questions if supplied prior to starting the activity. Users must read and study the activity in its entirety before completing the post-test questions.
  • Your results will be automatically saved and if a pass score is achieved (where applicable), you may be eligible to claim credit for the activity and receive a certificate of completion.

Additional Information

Course summary
Available credit: 
  • 1.00 European Board for Accreditation in Cardiology (EBAC)
Course opens: 
Course expires: 

Case Management Discussion 

  • Patient case study summary

  • Poll results and discussion 

Heart Failure Care 

  • Is it always the role of the cardiologist to start HF treatment? 

  • In whom and where can SGLT-2 inhibitors be initiated for HF?

  • When should SGLT-2 inhibitors be initiated? How can the team work effectively? 

Q&A and Discussion


Prof Andrew JS Coats - Heart Research Institute, Sydney, AU
Dr Katherine Tuttle - Providence Health Care, Seattle, WA, US
Prof Silvio Inzucchi - Yale University School of Medicine, New Haven, US
Prof Richard Hobbs - University of Oxford, Oxford, UK

Available Credit

  • 1.00 European Board for Accreditation in Cardiology (EBAC)
Please login or register to take this course.